Collaborative Study of 1,3 Butadiene Biomarkers
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Butadiene is a suspect human carcinogen to which most people are exposed daily. Exposures are difficult to measure by air sampling. This study examines the relationship between air levels and several biomarkers of exposure. Biomarkers are substances analyzed in human tissues or waste products. Adducts are materials formed when a chemical reacts with a biological material. In this study we are looking at biomarkers in the blood: hemoglobin and DNA adducts, and urinary metabolites. If a strong relationship is found then the amounts of biomarkers in a person's blood or urine can tell us how much they have been exposed. The tests are being conducted on petrochemical workers who have a wide range of exposures to butadiene. An international group of investigators is conducting the study.
| Condition |
|---|
|
Cancer |
| Study Type: | Observational |
| Study Design: | Observational Model: Defined Population Observational Model: Natural History Time Perspective: Longitudinal Time Perspective: Prospective |
Eligibility| Ages Eligible for Study: | 19 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Healthy adults without metabolic disorders
Contacts and Locations
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00023140 History of Changes |
| Other Study ID Numbers: | 9401-CP-001 |
| Study First Received: | August 22, 2001 |
| Last Updated: | March 22, 2006 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Institute of Environmental Health Sciences (NIEHS):
|
biomarkers exposure adducts metabolites butadiene |
ClinicalTrials.gov processed this record on May 22, 2013